{"id":8145,"date":"2026-09-18T13:17:38","date_gmt":"2026-09-18T13:17:38","guid":{"rendered":"https:\/\/www.nfp-drugs.bg\/en\/?p=8145"},"modified":"2026-10-07T12:42:47","modified_gmt":"2026-10-07T12:42:47","slug":"issue-17-of-news-bulletin-for-the-new-psychoactive-substances","status":"publish","type":"post","link":"https:\/\/www.nfp-drugs.bg\/en\/issue-17-of-news-bulletin-for-the-new-psychoactive-substances\/","title":{"rendered":"Issue 17 of NEWS bulletin for the new psychoactive substances"},"content":{"rendered":"\n<p>In issue 17 of the edition of the National Focal Point on Drugs and Drug Addictions NEWS bulletin for the new psychoactive substances you will find the following topics:<\/p>\n\n\n\n<ul>\n<li>New psychoactive substances identified in Bulgaria in the first half of 2026.<\/li>\n\n\n\n<li>New psychoactive substances identified in Europe in the first half of 2026.<\/li>\n\n\n\n<li>Monitoring of the new psychoactive substances on European level.<\/li>\n\n\n\n<li>Nine precursors for drug synthesis placed under EU control.<\/li>\n\n\n\n<li>Ketamine in Europe.<\/li>\n\n\n\n<li>European Drug Report 2026. &nbsp;Overview of new psychoactive substances on the European level.<\/li>\n\n\n\n<li>World Drug Report 2026. Global overview of new psychoactive substances.<\/li>\n<\/ul>\n\n\n\n<p style=\"padding-top:15px\"><strong><a href=\"https:\/\/www.nfp-drugs.bg\/wp-content\/uploads\/2026\/10\/NEWS_17.pdf\">Issue 17 of NEWS (in Bulgarian)<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In issue 17 of the edition of the National Focal Point on Drugs and Drug Addictions NEWS bulletin for the new psychoactive substances you will find the following topics: Issue 17 of NEWS (in Bulgarian)<\/p>\n","protected":false},"author":1,"featured_media":8147,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[],"_links":{"self":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/8145"}],"collection":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/comments?post=8145"}],"version-history":[{"count":2,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/8145\/revisions"}],"predecessor-version":[{"id":8154,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/8145\/revisions\/8154"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/media\/8147"}],"wp:attachment":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/media?parent=8145"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/categories?post=8145"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/tags?post=8145"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}